Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (191-200 of 280) with videos related to

Pageof 28
Sort By:
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Haematologica|January 2, 2015
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemiaFelicitas Thol, Michaela Scherr, Aylin Kirchner, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature Communications|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent responseAparna Gopal, Derek Tam, Franziska Mey, et al.
Hemasphere|April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaMareike Tometten, Martin Kirschner, Robert Meyer, et al.
Blood|June 4, 2026
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid LeukemiaChristopher S Hourigan, Lisanne Beugelink, Jad Othman, et al.
Annals of Hematology|June 15, 2017
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantationMichael Heuser, Razif Gabdoulline, Patrick Löffeld, et al.
Pageof 28

Showing results (191-200 of 280) with videos related to

Sort By:
Pageof 28
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Haematologica|January 2, 2015
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemiaFelicitas Thol, Michaela Scherr, Aylin Kirchner, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature Communications|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent responseAparna Gopal, Derek Tam, Franziska Mey, et al.
Hemasphere|April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaMareike Tometten, Martin Kirschner, Robert Meyer, et al.
Blood|June 4, 2026
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid LeukemiaChristopher S Hourigan, Lisanne Beugelink, Jad Othman, et al.
Annals of Hematology|June 15, 2017
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantationMichael Heuser, Razif Gabdoulline, Patrick Löffeld, et al.
Pageof 28